Ultragenyx: One Biotech IPO To Stalk This Week – Updated
Research - Update from Friday, January 31st at 9:45 AM ET Today the company revealed that it’s selling 5.76M shares at $21. What would have originally been … Continue Reading
PremiumMust Read
Obesity & PD-1: History Doesn’t Repeat But It Rhymes
The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical Submits 510(k) for Insulin Patch Pump
Modular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumLatest Posts
Why These “Delivery” Trades Delivered Profits This Month
Recap - The congrats this week went to PropThink contributor Ivan Deryugin for his early December suggestion to buy BDSI ahead of a crucial phase 3 readout. The position … Continue Reading
Read now
Three Updates on Three Names PropThink Suggested for the First Half of This Year
Research - With the JP Morgan Healthcare conference in the rearview, here are updates on a few names that PropThink suggested already this year, all of which … Continue Reading
Premium
Linzess Sales Ramp Reads Positive for Synergy Pharma
Research - Ironwood Pharmaceuticals (IRWD) reported financial results for the fourth quarter and full year 2013 on Tuesday morning. We’re interested primarily for the read-through on Synergy Pharmaceuticals … Continue Reading
Read now
Professional Investor Explains His Two Largest Healthcare Holdings
Interviews - Sarepta Therapeutics (SRPT) had a tumultous year, reaching an all-time high of $55.00 last October before tumbling to lows under $13.00 when the U.S. FDA suggested that the company would need to … Continue Reading
Read now
Updated: BioLife Solutions’ Uplisting, Debt Deal Provide Overlooked Opportunity
Research - Update after the bell, BioLife announces a 1:14 reverse split. Talk about timing. BioLife Solutions (BLFS) (which Mr. Deryugin wrote about this morning below and in advance … Continue Reading
Read now
What You Didn’t Miss this Week, but You Might Next
Insights - Our entire editorial team was in San Francisco this week for the annual confluence of biotech conferences – JP Morgan Healthcare, Biotech Showcase, and OneMedForum … Continue Reading
Read now